46 results
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
18 Jun 24
Entry into a Material Definitive Agreement
8:36am
populations in parallel and pursue those opportunities with the same commitment we do for children IPO: 2021 Financial Position: Runway into 2026 Founded
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
12 Jun 24
Regulation FD Disclosure
8:07am
position through rapid registration pathways Expand to adolescent and adult populations in parallel and pursue those opportunities with the same commitment
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
30 May 24
Day One Announces Sale of Priority Review Voucher for $108 Million
8:35am
through rapid registration pathways Expand to adolescent and adult populations in parallel and pursue those opportunities with the same commitment we
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
6 May 24
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
4:30pm
pathways Expand to adolescent and adult populations in parallel and pursue those opportunities with the same commitment we do for children Our Approach
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
24 Apr 24
Regulation FD Disclosure
8:01am
living with this disease and their families is crucial. There is so much to celebrate here.”
The Company continues its commitment to the pLGG community … is dedicated to helping patients with pLGG access OJEMDA and supporting their families throughout the treatment journey. As part of this commitment, we
8-K
EX-99.2
8decwgc44e7j5o qk
24 Apr 24
Regulation FD Disclosure
8:01am
8-K
EX-99.2
4x0j5nc
26 Feb 24
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.2
xwfdxjwjzlq
8 Jan 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
i95w9lqeee74t5y
8 Jan 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
x1w3lknsr97fa3y
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.2
g10v1f1v0uq635rofu1g
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.2
xun659ejxn
30 Oct 23
Regulation FD Disclosure
8:12am
S-3ASR
fddw1t
14 Sep 23
Automatic shelf registration
5:28pm
8-K
EX-99.2
4ba 5oqjxokr287
11 Sep 23
Regulation FD Disclosure
8:35am
8-K
EX-99.2
fqak27y9fi4akku jt
16 Aug 23
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
8:06am
8-K
EX-99.2
e92m1u88ha jz6gl2kr
7 Aug 23
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.1
5f4wt5p 2wmmn
12 Jun 23
Regulation FD Disclosure
8:07am
8-K
EX-1.1
r9xgb6o675jb0qyymgr
7 Jun 23
Day One Announces Pricing of Public Offering of Common Stock
5:00pm